News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Polydex Pharmaceuticals (POLXF) Reports Continued Robust Sales and Continued Earnings; Facility Improvements to Reduce Production Costs



9/16/2013 9:27:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TORONTO, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink:POLXF) (the "Company") reports that it has continued to experience high demand for product from its customers, resulting in increasing sales and collaborated investments into production upgrades and planned capital improvements.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES